Breast cancer

Breast cancer

Study finds no benefit of aspirin in preventing breast cancer recurrence

A recent study has found that aspirin does not decrease the risk of invasive cancer events among survivors of breast cancer. This research challenges the notion that aspirin could be used as a preventive measure for breast cancer recurrence.

While aspirin has been shown to have potential benefits in other areas, such as reducing the risk of heart attacks and strokes, this study suggests that it may not be effective in preventing the recurrence of breast cancer. Further research is needed to explore other potential preventive measures for breast cancer survivors.